Selecta Biosciences Inc:Selecta Biosciences Reports Second Quarter 2021 Financial Results And Provides Business Update.Q2 Revenue $19.7 Million.Q2 Revenue Estimate $7.1 Million -- Refinitiv Ibes Data.Selecta Biosciences - Cash, Cash Equivalents, Marketable Securities As Of June 30, 2021 Expected To Provide Runway Into Q3 Of 2023.Qtrly Basic Net Income Per Share Of $0.04.Qtrly Diluted Net Income Per Share $0.00.
精彩评论